CRYSTAL MOSTELLER HOPSON: Open Payments
NPI 1558548917 · NEWTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$877 in 39 payments from 16 companies in 2025. Trend: 2023 $407 · 2024 $783 · 2025 $877
Food & beverage: $877
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $199 |
| Novo Nordisk Inc | 4 | $129 |
| PFIZER INC. | 5 | $116 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $91 |
| Dexcom, Inc. | 4 | $80 |
| AstraZeneca Pharmaceuticals LP | 4 | $61 |
| CeQur Corporation | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Abbott Laboratories | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
Products named: VRAYLAR, Wegovy, CAPLYTA, Dexcom G6 Transmitter, BREZTRI, ELIQUIS, PREVNAR 20, QULIPTA.
Industry payments across NC — which companies pay providers there.
